Cabot (NYSE:CBT) Price Target Raised to $70.00

Cabot (NYSE:CBT) had its price objective hoisted by research analysts at JPMorgan Chase & Co. from $68.00 to $70.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has an “underweight” rating on the specialty chemicals company’s stock. JPMorgan Chase & Co.‘s price target points to a potential downside of 16.01% from the company’s current price.

A number of other brokerages have also weighed in on CBT. Jefferies Financial Group reissued a “buy” rating and set a $85.00 price objective on shares of Cabot in a report on Wednesday, February 4th. UBS Group boosted their price objective on shares of Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a report on Friday. Zacks Research raised shares of Cabot from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 27th. Mizuho boosted their price objective on shares of Cabot from $75.00 to $80.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Finally, Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a report on Saturday. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Cabot has a consensus rating of “Hold” and an average target price of $80.25.

Cabot Stock Down 1.4%

NYSE CBT traded down $1.19 on Wednesday, hitting $83.34. The stock had a trading volume of 52,938 shares, compared to its average volume of 435,073. The business’s fifty day moving average price is $74.48 and its 200 day moving average price is $70.73. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.45 and a quick ratio of 0.96. Cabot has a 52-week low of $58.33 and a 52-week high of $86.43. The stock has a market cap of $4.30 billion, a price-to-earnings ratio of 15.75, a price-to-earnings-growth ratio of 11.18 and a beta of 0.78.

Cabot (NYSE:CBT) last released its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.47 by $0.14. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The business had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.31 million. During the same period in the previous year, the company earned $1.90 earnings per share. The business’s revenue for the quarter was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Equities research analysts anticipate that Cabot will post 6.25 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of CBT. Torren Management LLC acquired a new position in shares of Cabot during the 4th quarter worth about $26,000. Smartleaf Asset Management LLC raised its position in shares of Cabot by 598.0% during the 3rd quarter. Smartleaf Asset Management LLC now owns 349 shares of the specialty chemicals company’s stock worth $27,000 after purchasing an additional 299 shares during the last quarter. Rothschild Investment LLC raised its position in shares of Cabot by 170.4% during the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after purchasing an additional 259 shares during the last quarter. Hantz Financial Services Inc. raised its position in shares of Cabot by 227.5% during the 3rd quarter. Hantz Financial Services Inc. now owns 429 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 298 shares during the last quarter. Finally, Global Retirement Partners LLC raised its position in shares of Cabot by 1,606.9% during the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 466 shares during the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.